Who owns MARKER THERAPEUTICS INC COM NEW?
- Ticker: MRKR
- CUSIP Number: 57055l206
Tip: Access positions for across all investors
Analyze quarterly positions in Marker Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Marker Therapeutics stock
Who bought or sold MARKER THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 1.6M | $1.5M | 0% | Sep 2025 |
|
| Blue Owl Capital Holdings | 554k | $495k | 0% | Sep 2025 |
|
| Aisling Capital Management | 325k | $290k | 0% | Sep 2025 |
|
| Vanguard Group | 300k | $268k | 9% | Sep 2025 |
|
| Renaissance Technologies | 106k | $95k | 53% | Sep 2025 |
|
| Geode Capital Management | 96k | $86k | 1% | Sep 2025 |
|
| Advisor Group Holdings | 81k | $72k | 314% | Sep 2025 |
|
| LPL Financial | 59k | $52k | -20% | Sep 2025 |
|
| Two Sigma Securities | 48k | $43k | 100% | Sep 2025 |
|
| Two Sigma Investments | 37k | $33k | 100% | Sep 2025 |
|
| Virtu Financial | 28k | $25k | 100% | Sep 2025 |
|
| Invst | 23k | $36k | 0% | Jun 2025 |
|
| XTX Topco | 22k | $19k | 100% | Sep 2025 |
|
| State Street Corporation | 21k | $19k | 0% | Sep 2025 |
|
| Creative Planning | 17k | $16k | 0% | Sep 2025 |
|
| Matrix Asset Advisors | 15k | $13k | 0% | Sep 2025 |
|
| Northern Trust | 11k | $9.7k | 0% | Sep 2025 |
|
| Ashton Thomas Private Wealth | 10k | $8.9k | 100% | Sep 2025 |
|
| UBS Group | 5.8k | $5.2k | 262% | Sep 2025 |
|
| BlackRock | 992.00 | $884.963200 | 0% | Sep 2025 |
|
| Morgan Stanley | 401.00 | $613.289400 | 100% | Jun 2025 |
|
| Wells Fargo & Company | 242.00 | $215.912400 | 4% | Sep 2025 |
|
| SBI Securities | 203.00 | $180.994800 | -88% | Sep 2025 |
|
| Group One Trading | 178.00 | $159.007400 | 0% | Sep 2025 |
|
| FMR | 150.00 | $133.995000 | 100% | Sep 2025 |
|
| Hilltop National Bank | 73.00 | $64.999200 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $20.999000 | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 23.00 | $20.999000 | -36% | Sep 2025 |
|
| Versant Capital Management | 15.00 | $13.000500 | 0% | Sep 2025 |
|
Who sold out of Marker Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Jun 2025 | 213k | $326k |
| Jane Street | Jun 2025 | 22k | $33k |
| Dimensional Fund Advisors | Jun 2025 | 16k | $24k |
| Susquehanna International | Jun 2025 | 12k | $19k |
| Raymond James Financial | Jun 2025 | 9.5k | $15k |
| Tower Research Capital | Jun 2025 | 3.4k | $5.2k |
| Riggs Asset Managment | Jun 2025 | 1.2k | $1.8k |